Trends in the Prevalence of Tobacco Use in the United States, 1991–1992 to 2004–2005
Abstract
Objective
This study examined changes in the prevalence of daily tobacco use in the United States between 1991–1992 and 2004–2005 by sociodemographic characteristics and psychiatric disorders.
Methods
Secondary analyses were performed using data from the National Longitudinal Alcohol Epidemiologic Survey, conducted in 1991–1992 (N=41,612), and wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions, conducted in 2004–2005 (N=34,653).
Results
Although the overall prevalence of past-year daily tobacco use decreased significantly, the reduction was not uniform across all segments of the population. In both surveys, past-year daily tobacco use was higher among respondents with a drug use disorder, an alcohol use disorder, and major depressive disorder and among individuals from socioeconomically disadvantaged groups. Declines in use were slower among individuals with a lifetime alcohol use disorder or major depressive disorder. The prevalence of past-year daily tobacco use did not decrease among Native Americans.
Conclusions
Individuals with substance use disorders or major depressive disorder and Native Americans reported higher rates of past-year daily tobacco use than the general population. These findings suggest the need to emphasize specific interventions for these groups.
Tobacco smoking is the leading preventable cause of premature death worldwide (1). The societal costs in terms of smoking-attributable productivity losses and smoking-related health care are substantial (2). Over the past few years, intensive educational campaigns aimed at raising awareness of the health consequences of tobacco smoking, increased taxes on tobacco (3), and legal restrictions on the locations where smoking is permitted (4–6) have contributed to a significant decline in the prevalence of smoking in the United States.
Little is known, however, about the extent to which smoke-free legislation and media campaigns have in the aggregate differentially influenced tobacco use across subpopulations (7,8). Smoking prevalence and trends are related to socioeconomic status, and socioeconomic status is linked in complex ways to sociodemographic correlates that are associated with health disparities (9,10). However, minority groups are often underrepresented in research, which has limited the ability to examine differences between and within racial-ethnic groups (10). A better understanding of smoking trends can help clinicians and policy makers identify groups for whom prevention and smoking cessation programs have been successful and groups that may need more targeted efforts. In particular, it is important to know whether the prevalence of smoking has declined among individuals with psychiatric disorders, who are at increased risk of smoking (11,12).
To fill this gap in knowledge, we examined changes in the prevalence of smoking from 1991–1992 to 2004–2005 stratified by sociodemographic characteristics and presence or absence of specific psychiatric disorders. We drew on data from two large, nationally representative samples of U.S. adults, the National Longitudinal Alcohol Epidemiologic Survey (NLAES), conducted in 1991–1992 (13), and wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), conducted in 2004–2005 (14).
Methods
Samples
The NLAES, conducted in 1991–1992, and its successor, the NESARC, conducted in 2001–2002 with a follow-up (wave 2) in 2004–2005, obtained data from nationally representative samples of the U.S. adult population, as described elsewhere (15,16). The target population for each survey was the U.S. general population age 18 years and older. Face-to-face interviews were conducted with 41,612 respondents in NLAES and with 34,653 respondents in NESARC wave 2. The NLAES response rate was 90%, and the NESARC wave 2 response rate was 86.7% (15–17). In both surveys, data were weighted to adjust for oversampling of certain groups (for example, age 18–24) and for missing data. The weighted data are representative of the U.S. adult population at the time of the survey.
Respondents in both surveys were informed in writing about the nature of the survey, the statistical uses of the survey data, the voluntary aspect of participation, and the federal laws regarding the strict confidentiality of the identifiable survey information. Respondents who consented to participate after receiving this information were interviewed (15). The research protocols, including informed consent procedures, received full human subjects review and approval from the U.S. Census Bureau and U.S. Office of Management and Budget (15).
Assessment
The sample design and field methods of the NLAES and the NESARC were nearly identical, as previously described (16). Both the NLAES and NESARC used the Alcohol Use Disorder and Associated Disabilities Interview Schedule–IV (DSM-IV version) (AUDADIS-IV), a fully structured diagnostic interview designed to be conducted in households and developed to advance measurement of substance use disorders and mental disorders in large-scale surveys (18–20). The AUDADIS-IV was administered in the NLAES with use of a paper-and-pencil instrument, whereas the AUDADIS-IV was computerized for the NESARC and responses were entered directly into laptop computers (15,20).
Tobacco use was assessed by the following question: “About how often did you usually (smoke/use) (name of tobacco category) in the last 12 months?” Daily smokers were defined as respondents who reported use of any tobacco product daily within the past 12 months.
Lifetime and past-year DSM-IV axis I disorders assessed by the AUDADIS-IV and examined in this study were major depression and alcohol and other substance abuse and dependence. AUDADIS-IV methods to diagnose these disorders have been described in detail elsewhere (21–24). The good-to-excellent test–retest reliability and the good-to-excellent convergent, discriminant, and construct validity of AUDADIS-IV substance use disorder diagnoses have been documented in general population and clinical samples, as described in detail elsewhere (18,21,25–27).
To be consistent with previous reports (28), estimated rates of alcohol or drug treatment utilization included treatment by both mental health professionals and non–mental health professionals. The former included outpatient visits to a physician, psychologist, or any other mental health professional; inpatient treatment in a drug detoxification or rehabilitation unit or hospital ward; and treatment in an emergency department. Non–mental health professionals included members of the clergy, employee assistance programs, family and social services, halfway houses, therapeutic communities, crisis centers, and self-help groups.
Sociodemographic measures included sex, age, race-ethnicity, nativity, education, marital status, and personal income (29).
Statistical analysis
We examined the prevalence and correlates of past-year daily tobacco use (anyone who used any tobacco product daily within the past 12 months) in each survey and compared them across the surveys. Prevalence of past-year daily tobacco use was computed separately for the NLAES and the NESARC wave 2, stratified by sociodemographic and clinical characteristics. Odds ratios were calculated to examine differences within strata (for example, men versus women) in each survey, as well as over time (for example, changes in prevalence among women in the NLAES and wave 2 of the NESARC). The effect of clinical risk factors, such as alcohol use disorders, was also examined after adjustment for differences in sociodemographic variables. A series of logistic regression models were used, in which past-year daily tobacco use was the outcome and the predictors were each covariate (for example, gender), the survey (NLAES versus NESARC), and their interaction. All analyses, including calculation of standard errors and 95% confidence intervals, were conducted with SUDAAN to adjust for the complex design used in both surveys (16).
Results
Prevalence of tobacco use
Past-year daily tobacco use was reported by 25.9% of NLAES respondents and 18.5% of NESARC respondents (p<.001). In both surveys, the odds of past-year daily tobacco use were significantly greater for males; younger individuals; individuals who were widowed, separated, or divorced (compared with those married or cohabiting); those with a lifetime or past-year drug or alcohol use disorder, lifetime or past-year major depressive disorder, or a family history of an alcohol use disorder; and those who had sought treatment for alcohol or drug use disorders during the year preceding the interview (Table 1).
| Characteristic | NLAES (N=41,612) | NESARC wave 2 (N=34,653) | ||||||
|---|---|---|---|---|---|---|---|---|
| % | SE | OR | 95% CI | % | SE | OR | 95% CI | |
| Total | 25.93 | .28 | 18.50 | .43 | ||||
| Sex | ||||||||
| Male | 28.12 | .42 | 1.24 | 1.18–1.31 | 20.28 | .52 | 1.25 | 1.17–1.34 |
| Female (reference) | 23.91 | .32 | 16.87 | .49 | ||||
| Age | ||||||||
| 20–34 | 29.01 | .49 | 1.84 | 1.71–1.97 | 21.86 | .74 | 1.89 | 1.71–2.08 |
| 35–54 | 28.93 | .46 | 1.83 | 1.71–1.95 | 21.07 | .68 | 1.80 | 1.64–1.97 |
| ≥55 (reference) | 18.21 | .40 | 12.92 | .36 | ||||
| Race-ethnicity | ||||||||
| White (reference) | 27.03 | .32 | 19.72 | .40 | ||||
| Black | 26.99 | .77 | 1.00 | .92–1.09 | 18.18 | .69 | .90 | .82−.99 |
| Native American | 31.78 | 3.57 | 1.26 | .90–1.75 | 32.41 | 2.46 | 1.95 | 1.56–2.45 |
| Asian | 14.32 | 1.33 | .45 | .36−.56 | 10.22 | 1.18 | .46 | .35−.60 |
| Hispanic | 17.03 | .87 | .55 | .49−.63 | 11.74 | .95 | .54 | .45−.65 |
| Nativity | ||||||||
| U.S. born (reference) | 27.22 | .30 | 19.88 | .38 | ||||
| Foreign born | 16.48 | .70 | .53 | .47−.59 | 9.96 | .50 | .45 | .40−.50 |
| Education | ||||||||
| Less than high school (reference) | 31.28 | .68 | 25.13 | 1.31 | ||||
| High school | 31.59 | .47 | 1.01 | .94–1.09 | 23.75 | .61 | .93 | .82–1.06 |
| At least some college | 20.28 | .34 | .56 | .52−.60 | 14.45 | .39 | .50 | .44−.57 |
| Marital status | ||||||||
| Married or cohabiting (reference) | 24.61 | .36 | 16.00 | .43 | ||||
| Widowed, separated, or divorced | 31.13 | .58 | 1.38 | 1.30–1.48 | 23.64 | .74 | 1.62 | 1.50–1.76 |
| Never married | 25.55 | .65 | 1.05 | .97–1.14 | 22.10 | .89 | 1.49 | 1.35–1.64 |
| Personal income | ||||||||
| $0–$19,999 (reference) | 30.32 | .51 | 21.15 | .56 | ||||
| $20,000–$34,999 | 28.50 | .65 | .92 | .85−.99 | 20.07 | .65 | .94 | .86–1.02 |
| $35,000–$69,999 | 22.21 | .73 | .66 | .60−.72 | 16.24 | .59 | .72 | .66−.79 |
| ≥$70,000 | 23.73 | .81 | .71 | .65−.79 | 9.57 | .66 | .39 | .34−.46 |
| Lifetime drug use disorder | ||||||||
| Yes | 55.96 | 3.72 | 3.69 | 2.72–4.99 | 41.46 | 1.08 | 3.90 | 3.58–4.24 |
| No (reference) | 25.63 | .28 | 15.37 | .39 | ||||
| Lifetime alcohol use disorder | ||||||||
| Yes | 40.72 | .67 | 2.34 | 2.20–2.49 | 28.67 | .71 | 2.66 | 2.44–2.89 |
| No (reference) | 22.66 | .30 | 13.14 | .38 | ||||
| Lifetime major depression | ||||||||
| Yes | 27.94 | .99 | 1.12 | 1.01–1.24 | 22.25 | .83 | 1.33 | 1.22–1.44 |
| No (reference) | 25.77 | .29 | 17.76 | .42 | ||||
| Past-year drug use disorder | ||||||||
| Yes | 58.92 | 2.74 | 4.20 | 3.34–5.28 | 51.22 | 2.13 | 4.88 | 4.10–5.82 |
| No (reference) | 25.46 | .28 | 17.70 | .43 | ||||
| Past-year alcohol use disorder | ||||||||
| Yes | 45.29 | 1.17 | 2.56 | 2.32–2.82 | 34.31 | 1.12 | 2.58 | 2.34–2.86 |
| No (reference) | 24.45 | .29 | 16.81 | .42 | ||||
| Past-year major depression | ||||||||
| Yes | 39.33 | 1.54 | 1.89 | 1.66–2.17 | 24.36 | 1.29 | 1.45 | 1.27–1.66 |
| No (reference) | 25.49 | .29 | 18.15 | .42 | ||||
| Family history of alcohol use disorder | ||||||||
| Yes | 32.60 | .48 | 1.64 | 1.56–1.73 | 23.96 | .64 | 1.70 | 1.59–1.82 |
| No (reference) | 22.77 | .32 | 15.63 | .40 | ||||
| Past-year treatment for an alcohol use disorder | ||||||||
| Yes | 69.50 | 3.34 | 3.06 | 2.21–4.24 | 55.94 | 4.00 | 2.62 | 1.89–3.64 |
| No (reference) | 42.66 | 1.18 | 32.62 | 1.12 | ||||
| Past-year treatment for a drug use disorder | ||||||||
| Yes | 78.78 | 5.56 | 2.79 | 1.43–5.46 | 74.50 | 5.01 | 3.32 | 1.84–5.99 |
| No (reference) | 57.07 | 2.79 | 46.80 | 2.43 | ||||
| Past-year treatment for a drug or alcohol use disorder | ||||||||
| Yes | 69.86 | 3.12 | 3.04 | 2.23–4.13 | 59.49 | 3.20 | 2.90 | 2.20–3.82 |
| No (reference) | 43.29 | 1.15 | 33.65 | 1.04 | ||||
a
NLAES, National Longitudinal Alcohol Epidemiologic Survey, conducted in 1991–1992; NESARC, National Epidemiologic Survey on Alcohol and Related Conditions, conducted in 2001–2002 with a follow-up (wave 2) in 2004–2005.
In both surveys, the odds of past-year daily tobacco use were significantly lower for Asians and Hispanics, compared with whites; foreign-born individuals; those with at least some college, compared with those with less than a high school education; and those with an income greater than $35,000, compared with those with an income less than $19,999. Furthermore, in the NLAES, the odds of past-year daily tobacco use were lower for individuals with an income between $20,000 and $34,999, compared with those with an income of $19,999 or less, but this effect was not present in the NESARC. The odds of past-year daily tobacco use were higher for Native Americans and individuals who were never married and lower for blacks only in the NESARC.
After adjustment for sociodemographic characteristics, the effects of all clinical factors remained unchanged (data not shown), except for major depression in the NLAES, which was no longer a significant predictor of daily use.
Trends in the prevalence of tobacco use
The prevalence of past-year daily tobacco use significantly decreased across most sociodemographic and clinical groups between 1991–1992 and 2004–2005. The only exceptions were the lack of significant changes in the prevalence of past-year daily tobacco use among Native Americans and among those who had sought treatment for a drug use disorder during the year preceding the interview (Table 2).
| Variable | Time effect within group | Sociodemographic or clinical variable × time interaction termb | ||
|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |
| Total | ||||
| Sex | ||||
| Male | .65 | .60−.70 | 1.01 | .93–1.10 |
| Female (reference) | .65 | .60−.70 | ||
| Age | ||||
| 20–34 | .68 | .62−.76 | 1.03 | .91–1.16 |
| 35–54 | .66 | .60−.72 | .98 | .88–1.10 |
| ≥55 (reference) | .67 | .61−.72 | ||
| Race-ethnicity | ||||
| White (reference) | .66 | .62−.70 | ||
| Black | .60 | .53−.68 | .90 | .80–1.03 |
| Native American | 1.02 | .69–1.52 | 1.54 | 1.03–2.30 |
| Asian | .68 | .48−.95 | 1.02 | .72–1.45 |
| Hispanic | .65 | .52−.81 | .98 | .79–1.22 |
| Nativity | ||||
| U.S. born (reference) | .66 | .63−.70 | ||
| Foreign born | .56 | .48−.65 | .84 | .73−.98 |
| Education | ||||
| Less than high school (reference) | .74 | .63−.86 | ||
| High school | .67 | .62−.73 | .92 | .79–1.06 |
| At least some college | .66 | .62−.72 | .90 | .77–1.05 |
| Marital status | ||||
| Married or cohabiting (reference) | .58 | .54−.63 | ||
| Widowed, separated, or divorced | .69 | .62−.76 | 1.17 | 1.06–1.30 |
| Never married | .83 | .73−.94 | 1.42 | 1.25–1.61 |
| Personal income | ||||
| $0–$19,999 (reference) | .62 | .57−.67 | ||
| $20,000–$34,999 | .63 | .57−.70 | 1.02 | .91–1.14 |
| $35,000–$69,999 | .68 | .60−.77 | 1.10 | .96–1.26 |
| ≥$70,000 | .34 | .29−.41 | .55 | .46−.66 |
| Lifetime drug use disorder | ||||
| Yes | .56 | .41−.76 | 1.06 | .77–1.45 |
| No (reference) | .53 | .49−.56 | ||
| Lifetime alcohol use disorder | ||||
| Yes | .59 | .54−.64 | 1.13 | 1.02–1.26 |
| No (reference) | .52 | .48–.56 | ||
| Lifetime major depression | ||||
| Yes | .74 | .64−.85 | 1.19 | 1.04–1.35 |
| No (reference) | .62 | .58−.66 | ||
| Family history of alcohol use disorder | ||||
| Yes | .65 | .60−.71 | 1.04 | .95–1.13 |
| No (reference) | .63 | .59−.67 | ||
| Past-year drug use disorder | ||||
| Yes | .73 | .55−.97 | 1.16 | .87–1.55 |
| No (reference) | .63 | .59−.67 | ||
| Past-year alcohol use disorder | ||||
| Yes | .63 | .55−.72 | 1.01 | .88–1.16 |
| No (reference) | .62 | .58−.67 | ||
| Past-year major depression | ||||
| Yes | .50 | .41−.60 | .77 | .64−.92 |
| No (reference) | .65 | .61−.69 | ||
| Past-year treatment for an alcohol use disorder | ||||
| Yes | .56 | .35−.87 | .86 | .54–1.36 |
| No (reference) | .65 | .57−.75 | ||
| Past-year treatment for a drug use disorder | ||||
| Yes | .79 | .34–1.84 | 1.19 | .49–2.90 |
| No (reference) | .66 | .49−.89 | ||
| Past-year treatment for a substance use disorder | ||||
| Yes | .63 | .43−.94 | .95 | .63–1.44 |
| No (reference) | .66 | .58−.76 | ||
a
NLAES, National Longitudinal Alcohol Epidemiologic Survey, conducted in 1991–1992; NESARC, National Epidemiologic Survey on Alcohol and Related Conditions, conducted in 2001–2002 with a follow-up (wave 2) in 2004–2005
b
NLAES is the reference group for the time component of the interaction.
The interaction terms of prevalence of past-year daily tobacco use with some sociodemographic and clinical correlates were significant (Table 2). The prevalence of past-year daily use between 1991–1992 and 2004–2005 decreased at a faster rate among whites than among Native Americans and among foreign-born persons than among those born in the United States. The prevalence of past-year daily tobacco use decreased at a faster rate among those married or cohabitating than among those never married, widowed, separated, or divorced. It also decreased at a faster rate among those with personal income of at least $70,000 compared with those with an income below $20,000. Furthermore, the prevalence decreased faster among individuals with no lifetime alcohol use disorder than among those with a lifetime alcohol use disorder and among those without lifetime or past-year major depression than those with lifetime or past-year major depression.
Discussion
To our knowledge, this is the first study to examine changes in the prevalence of tobacco use in the United State stratified by sociodemographic characteristics and clinical correlates. We have emphasized four major results. First, although the prevalence of past-year daily tobacco use decreased significantly from 1991–1992 to 2004–2005, the reduction was not uniform across all segments of the population. Second, in both time periods, past-year daily use was higher among individuals with lifetime and past-year drug or alcohol use disorders and major depressive disorder. Third, for individuals with a lifetime alcohol use disorder or lifetime or past-year major depressive disorder, the decline in past-year daily tobacco use was slower than for individuals without these disorders. Fourth, in both surveys, the odds of past-year daily tobacco use were greater among individuals from socioeconomically disadvantaged groups, such as those with lower income or educational attainment. Furthermore, the prevalence of past-year daily use did not decrease between the two periods among Native Americans.
Consistent with findings from previous studies (30,31), the overall prevalence of past-year daily tobacco use in the United States decreased between 1991–1992 and 2004–2005. A number of changes in public policies, including progressively more stringent laws restricting smoking in the workplace and in public places (30,32–35), increases in the price of cigarettes (33), and continued antismoking media campaigns (36,37), appear to have had a synergistic effect in decreasing tobacco use.
Despite the general decline in tobacco use, the reduction was not uniform across all sociodemographic groups. Consistent with data from clinical (38) and community (12,39,40) studies, past-year daily tobacco use was higher among persons with drug use disorders and with alcohol use disorders. Several factors may contribute to the high prevalence of daily smoking among individuals with a substance use disorder. Tobacco smoking by individuals with another drug use disorder may indicate a shared genetic vulnerability (41), more severe nicotine addiction (42), or an abnormal response to alternative rewarding activities due to an activation of the prefrontal cortex and glutamatergic drive to the nucleus accumbens (43), all of which may increase the difficulty of quitting (44,45). In addition, smokers who have a drug use disorder may underestimate the risk of tobacco use compared with smokers who do not have a drug use disorder. Some individuals may use nicotine in an attempt to relieve their psychiatric symptoms (46). Furthermore, some drugs, such as cannabis, are commonly smoked, and cannabis users may be more likely to be cigarette smokers and vice versa. The use of one substance may trigger the use of the others either through associated environmental factors, such as cues or peer use, or by shared pharmacological mechanisms (47).
Many substance abuse treatment programs do not incorporate smoking cessation into treatment (48), and some programs may even encourage patients to delay smoking cessation for fear that it might precipitate relapse into drug use (12,49). This approach may contribute to the high rates of smoking seen among individuals in substance abuse treatment (12). Concerns about relapse to drug use after smoking cessation have not been supported by most studies (48,50,51), and evidence suggests that smoking cessation may facilitate abstinence from other drugs and alcohol (48,52–54). Given the high prevalence of tobacco use among patients seeking substance abuse treatment, smoking cessation interventions should be part of any comprehensive approach to addiction treatment (54,55).
Past-year daily tobacco use was higher among individuals with major depressive disorder, and the decline in past-year daily tobacco use was slower among those with major depressive disorder. Research has documented a strong association between depression and nicotine dependence and between depression and daily and occasional smoking (47,56–59). Although some evidence suggests the presence of a causal relationship between smoking and depression, the direction of the relationship remains unclear (60). Some population studies suggest that a substantial component of the association between smoking and depression is noncausal and that the association might be due to common predisposing factors (60) or might arise because the risk factors and life processes associated with the development of smoking and depression are correlated and tend to overlap (61).
Health care providers should consider encouraging patients who have significant depressive symptoms or depression histories to seek smoking cessation services that include both typical smoking cessation treatments and behavioral mood management (62).
Taken together, these results suggest that individuals with drug use disorders and depression benefit less from traditional public policies and antismoking media campaigns. Our findings, underscore the importance of developing innovative prevention and treatment strategies directed at curtailing tobacco use in these populations (63,64).
In both surveys, the odds of past-year daily tobacco use were greater among individuals from disadvantaged groups, such as those with lower income or educational attainment. Moreover, past-year daily tobacco use did not decrease among Native Americans, contrary to trends among most other sociodemographic groups. The association between tobacco use and low educational attainment and income is a consistent finding in epidemiologic and clinical studies (9,65–70), although the causal direction is unclear. Familial vulnerability (67), differential valuations of the health consequences of smoking (71), and differences in access to and effectiveness of cessation treatments (72,73) may explain the prevalence of tobacco use among those with low educational attainment and income. Also, there is evidence that marketing tactics of the tobacco industry target low-income and minority communities to influence smoking-uptake patterns (74) and that some types of smoking cessation media messages may have greater impact on quit attempts among populations with more education (75). These findings suggest the need for specific interventions to reduce the incidence of smoking in these vulnerable groups (44,66,76). Other studies have demonstrated increased rates of smoking among Native Americans (77–80). Our findings indicate that this health disparity may be increasing among Native Americans. Longitudinal research using data from NESARC waves 1 and 2 could examine prospective associations to examine health disparities among high-risk subgroups of the population.
This study had several limitations. First, information on tobacco use was based on self-report and not confirmed with biological measures. Therefore, reporting bias, such as social desirability, cannot be ruled out. However, prior analyses of the NLAES and NESARC that focused on less socially acceptable behaviors (for example, shoplifting) have found prevalence estimates similar to those documented by other studies (81), suggesting that the effect of social desirability bias may not be large. Second, because the NLAES and NESARC sampled only persons age 18 and older in civilian households and group quarters, information was unavailable on groups such as adolescents or prisoners, for whom rates of tobacco use may differ. Third, because the NLAES did not assess nicotine dependence, the study focused on daily tobacco use. However, NESARC data indicated that 86.7% of individuals with nicotine dependence smoked daily, suggesting a high degree of overlap between these two categories. Fourth, our study focused on daily smoking. Future research should examine trends in nondaily smoking because research has shown that this pattern of smoking is associated with substance use disorders and other psychiatric disorders (82).
Conclusions
Although the overall prevalence of tobacco use in the United States decreased from 1991–1992 to 2004–2005, vulnerable populations reported disproportionately higher rates of use. Individuals with drug or alcohol use disorders or with major depressive disorder and Native Americans continued to report rates of daily smoking that were higher than rates in the general population. We hope that this information can help guide clinicians and policy makers in developing and implementing interventions that will continue to reduce tobacco-related illness.
Acknowledgments and disclosures
NLAES and NESARC were sponsored by the National Institute on Alcohol Abuse and Alcoholism. Work on this article was supported by grants DA019606, DA020783, DA023200, and DA023973 from the National Institute on Drug Abuse; grant CA133050 from the National Cancer Institute; the New York State Psychiatric Institute; and grant PR2010-0501 from the Spanish Ministry of Education.
Dr. Olfson has received grant support from Eli Lilly and Company and Bristol-Myers Squibb. The other authors report no competing interests.
References
1.
WHO Global Report: Mortality Attributable to Tobacco. Geneva, World Health Organization, 2012
2.
Hays JT, Ebbert JO, Sood A: Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guideline. Mayo Clinic Proceedings 84:730–735, 2009
3.
Debrot K, Tynan M, Francis J, et al.: State cigarette excise taxes: United States, 2009. Morbidity and Mortality Weekly Report 59:385–388, 2010
4.
Cheng KW, Glantz SA, Lightwood JM: Association between smokefree laws and voluntary smokefree-home rules. American Journal of Preventive Medicine 41:566–572, 2011
5.
Hahn EJ: Smokefree legislation: a review of health and economic outcomes research. American Journal of Preventive Medicine 39(suppl 1):S66–S76, 2010
6.
Kanjilal S, Gregg EW, Cheng YJ, et al.: Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971–2002. Archives of Internal Medicine 166:2348–2355, 2006
7.
Breslau N, Johnson EO, Hiripi E, et al.: Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Archives of General Psychiatry 58:810–816, 2001
8.
Danaei G, Rimm EB, Oza S, et al.: The promise of prevention: the effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United States. PLoS Medicine 7:e1000248, 2010
9.
Cokkinides V, Bandi P, McMahon C, et al.: Tobacco control in the United States: recent progress and opportunities. CA: a Cancer Journal for Clinicians 59:352–365, 2009
10.
Fagan P, Moolchan ET, Lawrence D, et al.: Identifying health disparities across the tobacco continuum. Addiction 102(suppl 2):5–29, 2007
11.
Kang E, Lee J: A longitudinal study on the causal association between smoking and depression. Journal of Preventive Medicine and Public Health 43:193–204, 2010
12.
Richter KP, Ahluwalia HK, Mosier MC, et al.: A population-based study of cigarette smoking among illicit drug users in the United States. Addiction 97:861–869, 2002
13.
Grant BF, Harford TC, Dawson DA, et al.: Prevalence of DSM-IV alcohol abuse and dependence: United States, 1992. Alcohol Health and Research World 18:243–248, 1994
14.
Grant BF, Kaplan KK, Stinson FS: Source and Accuracy Statement: The Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Bethesda, Md, National Institute on Alcohol Abuse and Alcoholism, 2007
15.
Blanco C, Alderson D, Ogburn E, et al.: Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug and Alcohol Dependence 90:252–260, 2007
16.
Compton WM, Grant BF, Colliver JD, et al.: Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA 291:2114–2121, 2004
17.
Ruan WJ, Goldstein RB, Chou SP, et al.: The Alcohol Use Disorder and Associated Disabilities Interview Schedule–IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug and Alcohol Dependence 92:27–36, 2008
18.
Grant BF, Dawson DA, Stinson FS, et al.: The Alcohol Use Disorder and Associated Disabilities Interview Schedule–IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug and Alcohol Dependence 71:7–16, 2003
19.
Grant BF, Dawson DA, Stinson FS, et al.: The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug and Alcohol Dependence 74:223–234, 2004
20.
McCabe SE, Cranford JA, West BT: Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addictive Behaviors 33:1297–1305, 2008
21.
Compton WM, Thomas YF, Stinson FS, et al.: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 64:566–576, 2007
22.
Cox BJ, Turnbull DL, Robinson JA, et al.: The effect of avoidant personality disorder on the persistence of generalized social anxiety disorder in the general population: results from a longitudinal, nationally representative mental health survey. Depression and Anxiety 28:250–255, 2011
23.
Grant BF, Hasin DS, Stinson FS, et al.: Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological Medicine 35:1747–1759, 2005
24.
Hellerstein DJ, Agosti V, Bosi M, et al.: Impairment in psychosocial functioning associated with dysthymic disorder in the NESARC study. Journal of Affective Disorders 127:84–88, 2010
25.
Hasin DS, Goodwin RD, Stinson FS, et al.: Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry 62:1097–1106, 2005
26.
Pietrzak RH, Goldstein RB, Southwick SM, et al.: Personality disorders associated with full and partial posttraumatic stress disorder in the US population: results from wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Psychiatric Research 45:678–686, 2011
27.
Goldstein RB, Dawson DA, Grant BF: Antisocial behavioral syndromes in adulthood and alcohol use disorder treatment over three-year follow-up: results from wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of the American Psychiatric Nurses Association 16:212–226, 2010
28.
Wang PS, Lane M, Olfson M, et al.: Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Archives of General Psychiatry 62:629–640, 2005
29.
Agrawal A, Lynskey MT: Tobacco and cannabis co-occurrence: does route of administration matter? Drug and Alcohol Dependence 99:240–247, 2009
30.
Pierce JP, Messer K, White MM, et al.: Prevalence of heavy smoking in California and the United States, 1965–2007. JAMA 305:1106–1112, 2011
31.
Goodwin RD, Keyes KM, Hasin DS: Changes in cigarette use and nicotine dependence in the United States: evidence from the 2001–2002 wave of the National Epidemiologic Survey of Alcoholism and Related Conditions. American Journal of Public Health 99:1471–1477, 2009
32.
State smoke-free laws for worksites, restaurants, and bars: United States, 2000–2010. Morbidity and Mortality; Weekly Report 60:472–475, 2011
33.
Fichtenberg CM, Glantz SA: Effect of smoke-free workplaces on smoking behaviour: systematic review. British Medical Journal 325:188, 2002
34.
Hopkins DP, Razi S, Leeks KD, et al.: Smokefree policies to reduce tobacco use: a systematic review. American Journal of Preventive Medicine 38(suppl):S275–S289, 2010
35.
McMullen KM, Brownson RC, Luke D, et al.: Strength of clean indoor air laws and smoking related outcomes in the USA. Tobacco Control 14:43–48, 2005
36.
Emery S, Kim Y, Choi YK, et al.: The effects of smoking-related television advertising on smoking and intentions to quit among adults in the United States: 1999–2007. American Journal of Public Health 102:751–757, 2012
37.
Ibrahim JK, Glantz SA: The rise and fall of tobacco control media campaigns, 1967– 2006. American Journal of Public Health 97:1383–1396, 2007
38.
Guydish J, Passalacqua E, Tajima B, et al.: Smoking prevalence in addiction treatment: a review. Nicotine and Tobacco Research 13:401–411, 2011
39.
Black DW, Zimmerman M, Coryell WH: Cigarette smoking and psychiatric disorder in a community sample. Annals of Clinical Psychiatry 11:129–136, 1999
40.
Lai S, Lai H, Page JB, et al.: The association between cigarette smoking and drug abuse in the United States. Journal of Addictive Diseases 19:11–24, 2000
41.
Edwards AC, Maes HH, Pedersen NL, et al.: A population-based twin study of the genetic and environmental relationship of major depression, regular tobacco use and nicotine dependence. Psychological Medicine 41:395–405, 2011
42.
Kalman D, Morissette SB, George TP: Co-morbidity of smoking in patients with psychiatric and substance use disorders. American Journal on Addictions 14:106–123, 2005
43.
Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice. American Journal of Psychiatry 162:1403–1413, 2005
44.
Breslau N, Peterson E, Schultz L, et al.: Are smokers with alcohol disorders less likely to quit? American Journal of Public Health 86:985–990, 1996
45.
Lasser K, Boyd JW, Woolhandler S, et al.: Smoking and mental illness: a population-based prevalence study. JAMA 284:2606–2610, 2000
46.
Glassman AH: Cigarette smoking: implications for psychiatric illness. American Journal of Psychiatry 150:546–553, 1993
47.
Grant BF, Hasin DS, Chou SP, et al.: Nicotine dependence and psychiatric disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 61:1107–1115, 2004
48.
Patkar AA, Mannelli P, Peindl K, et al.: Changes in tobacco smoking following treatment for cocaine dependence. American Journal of Drug and Alcohol Abuse 32:135–148, 2006
49.
Sees KL, Clark HW: When to begin smoking cessation in substance abusers. Journal of Substance Abuse Treatment 10:189–195, 1993
50.
Hall SM: Nicotine interventions with comorbid populations. American Journal of Preventive Medicine 33(suppl):S406–S413, 2007
51.
Hurt RD, Eberman KM, Croghan IT, et al.: Nicotine dependence treatment during inpatient treatment for other addictions: a prospective intervention trial. Alcoholism, Clinical and Experimental Research 18:867–872, 1994
52.
Prochaska JJ, Delucchi K, Hall SM: A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology 72:1144–1156, 2004
53.
Tsoh JY, Chi FW, Mertens JR, et al.: Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. Drug and Alcohol Dependence 114:110–118, 2011
54.
Sullivan MA, Covey LS: Current perspectives on smoking cessation among substance abusers. Current Psychiatry Reports 4:388–396, 2002
55.
Guydish J, Tajima B, Kulaga A, et al.: The New York policy on smoking in addiction treatment: findings after 1 year. American Journal of Public Health 102:e17–e25, 2012
56.
Goodwin RD, Lavoie KL, Lemeshow AR, et al.: Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine and Tobacco Research 14:176–183, 2012
57.
Hebert KK, Cummins SE, Hernández S, et al.: Current major depression among smokers using a state quitline. American Journal of Preventive Medicine 40:47–53, 2011
58.
Manley MJ, de Jonge P, Kershaw TS, et al.: Association of major depression with subtypes of nicotine dependence found among adult daily smokers: a latent class analysis. Drug and Alcohol Dependence 104:126–132, 2009
59.
Wiesbeck GA, Kuhl HC, Yaldizli O, et al.: Tobacco smoking and depression: results from the WHO/ISBRA study. Neuropsychobiology 57:26–31, 2008
60.
Breslau N, Kilbey MM, Andreski P: Nicotine dependence and major depression. New evidence from a prospective investigation. Archives of General Psychiatry 50:31–35, 1993
61.
Fergusson DM, Goodwin RD, Horwood LJ: Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychological Medicine 33:1357–1367, 2003
62.
Gierisch JM, Bastian LA, Calhoun PS, et al.: Smoking cessation interventions for patients with depression: a systematic review and meta-analysis. Journal of General Internal Medicine 27:351–360, 2012
63.
Duffy SA, Kilbourne AM, Austin KL, et al.: Risk of smoking and receipt of cessation services among veterans with mental disorders. Psychiatric Services 63:325–332, 2012
64.
Ferron JC, Brunette MF, He X, et al.: Course of smoking and quit attempts among clients with co-occurring severe mental illness and substance use disorders. Psychiatric Services 62:353–359, 2011
65.
Fergusson DM, Horwood LJ, Boden JM, et al.: Childhood social disadvantage and smoking in adulthood: results of a 25-year longitudinal study. Addiction 102:475–482, 2007
66.
Filion KB, Steffen LM, Duval S, et al.: Trends in smoking among adults from 1980 to 2009: the Minnesota Heart Survey. American Journal of Public Health 102:705–713, 2012
67.
Gilman SE, Martin LT, Abrams DB, et al.: Educational attainment and cigarette smoking: a causal association? International Journal of Epidemiology 37:615–624, 2008
68.
Graham H: Women and smoking: understanding socioeconomic influences. Drug and Alcohol Dependence 104(suppl 1):S11–S16, 2009
69.
Higgins ST, Chilcoat HD: Women and smoking: an interdisciplinary examination of socioeconomic influences. Drug and Alcohol Dependence 104(suppl 1):S1–S5, 2009
70.
Huisman M, Kunst AE, Mackenbach JP: Inequalities in the prevalence of smoking in the European Union: comparing education and income. Preventive Medicine 40:756–764, 2005
71.
Cowell AJ: The relationship between education and health behavior: some empirical evidence. Health Economics 15:125–146, 2006
72.
Fernández E, Schiaffino A, Borrell C, et al.: Social class, education, and smoking cessation: long-term follow-up of patients treated at a smoking cessation unit. Nicotine and Tobacco Research 8:29–36, 2006
73.
Sheffer CE, Stitzer M, Landes R, et al.: Socioeconomic disparities in community-based treatment of tobacco dependence. American Journal of Public Health 102:e8–e16, 2012
74.
Barbeau EM, Leavy-Sperounis A, Balbach ED: Smoking, social class, and gender: what can public health learn from the tobacco industry about disparities in smoking? Tobacco Control 13:115–120, 2004
75.
Niederdeppe J, Fiore MC, Baker TB, et al.: Smoking-cessation media campaigns and their effectiveness among socioeconomically advantaged and disadvantaged populations. American Journal of Public Health 98:916–924, 2008
76.
Johnson EO, Novak SP: Onset and persistence of daily smoking: the interplay of socioeconomic status, gender, and psychiatric disorders. Drug and Alcohol Dependence 104(suppl 1):S50–S57, 2009
77.
Beals J, Manson SM, Whitesell NR, et al.: Prevalence of DSM-IV disorders and attendant help-seeking in two American Indian reservation populations. Archives of General Psychiatry 62:99–108, 2005
78.
Duran B, Sanders M, Skipper B, et al.: Prevalence and correlates of mental disorders among Native American women in primary care. American Journal of Public Health 94:71–77, 2004
79.
Olson LM, Wahab S: American Indians and suicide: a neglected area of research. Trauma, Violence and Abuse 7:19–33, 2006
80.
Forster JL, Brokenleg I, Rhodes KL, et al.: Cigarette smoking among American Indian youth in Minneapolis–St. Paul. American Journal of Preventive Medicine 35(suppl):S449–S456, 2008
81.
Blanco C, Grant J, Petry NM, et al.: Prevalence and correlates of shoplifting in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). American Journal of Psychiatry 165:905–913, 2008
82.
Harrison ELR, McKee SA: Non-daily smoking predicts hazardous drinking and alcohol use disorders in young adults in a longitudinal US sample. Drug and Alcohol Dependence 118:78–82, 2011
Information & Authors
Information
Published In
Cover: Portrait of a Woman, by William Beckman, ca. 1988. Oil on board. Photo credit: Jerry L. Thompson/Art Resource, New York City.
History
Published in print: May 2013
Published online: 15 October 2014
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).